510(k) · Cleared
ClearedJAX
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Smith & Nephew, Inc. · MQV Filler, Bone Void, Calcium Compound
Cleared on Feb 25, 2003 after a 729-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 6 later devices descend from it.
- Decided
- Feb 25, 2003
- Review
- 729 days
- Class
- Class II
- Product code
- MQV
- Recalls
- None
- Predicates
- 0
6 later devices descend from it, 2 citing it directly.
- This deviceK010555 JAXSmith & Nephew, Inc. · 2003
- Descendant · cites it directly · 4 of its ownK041421 Name Bone Void FillerStryker Biotech · 2004 · Recalled
- Descendant · 2 generations on · 3 of its ownK051722 Tricos TBaxter Healthcare Corp · 2005
- Descendant · 3 generations on · 2 of its ownK073571 Tricos T Resorbable Bone SubstituteBaxter Healthcare Corporation · 2008
- Descendant · 3 generations on · 0 of its ownK081717 Tricos a Resorbable Bone SubstituteBaxter Healthcare Corp · 2008
- Descendant · 3 generations on · 0 of its ownK081721 Tricos a Resorbable SubstituteBaxter Healthcare Corp · 2008
Showing 5 of 6 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 6 · See all- K041421Name Bone Void FillerStryker Biotech · 2004 · cites it directly4descendants
- K051722Tricos TBaxter Healthcare Corp · 2005 · 2 generations on3descendants
- K073571Tricos T Resorbable Bone SubstituteBaxter Healthcare Corporation · 2008 · 3 generations on2descendants
- K081717Tricos a Resorbable Bone SubstituteBaxter Healthcare Corp · 2008 · 3 generations on0descendants
- K081721Tricos a Resorbable SubstituteBaxter Healthcare Corp · 2008 · 3 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K010555 | JAX | Smith & Nephew, Inc. | 2003 | — |
| +1 | K041421 | Name Bone Void Filler | Stryker Biotech | 2004 | 1 |
| +2 | K051722 | Tricos T | Baxter Healthcare Corp | 2005 | — |
| +3 | K073571 | Tricos T Resorbable Bone Substitute | Baxter Healthcare Corporation | 2008 | — |
| +3 | K081717 | Tricos a Resorbable Bone Substitute | Baxter Healthcare Corp | 2008 | — |
| +3 | K081721 | Tricos a Resorbable Substitute | Baxter Healthcare Corp | 2008 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2004 | 1 | 0 |
| 2005 | 2 | 0 |
| 2008 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MQV device
- #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
FDA has not posted a summary or statement for it, so its predicates are not known.
What descends from it? (6)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K041421 (Stryker Biotech, 2004) has gone furthest, with 4 descendants of its own.
How does its category compare?
All MQV devicesMQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MQV
14in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MQV
57in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MQV
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MQV
57in 2025
MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 35 | 144 | 5 | 67 |
| 2008 | 32 | 102 | 3 | 71 |
| 2009 | 23 | 180 | 1 | 81 |
| 2010 | 17 | 147 | 0 | 68 |
| 2011 | 16 | 92 | 6 | 114 |
| 2012 | 9 | 107 | 3 | 149 |
| 2013 | 12 | 197 | 2 | 223 |
| 2014 | 20 | 153 | 0 | 111 |
| 2015 | 18 | 184 | 0 | 125 |
| 2016 | 8 | 214 | 1 | 106 |
| 2017 | 17 | 124 | 1 | 107 |
| 2018 | 23 | 124 | 2 | 86 |
| 2019 | 13 | 90 | 0 | 65 |
| 2020 | 15 | 132 | 1 | 126 |
| 2021 | 8 | 88 | 0 | 101 |
| 2022 | 9 | 118 | 0 | 47 |
| 2023 | 21 | 74 | 3 | 120 |
| 2024 | 28 | 55 | 2 | 68 |
| 2025 | 14 | 57 | 1 | 57 |
| 2026 | 5 | 96 | 4 | — |
https://510kreport.com/device/K010555 · printed Nov 5, 2026
Cite this page
510(k) Report. “K010555: JAX.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K010555
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026